Location History:
- Sylvan Lake, MI (US) (1982)
- Los Angeles, CA (US) (1989)
- Farmington Hills, MI (US) (2000)
- Encino, CA (US) (1993 - 2007)
Company Filing History:
5 out of 2,285 
3 out of 136 
2 out of 2 
Years Active: 1982-2007
Title: George A. Sachs: Innovator in Pancreatic Treatment
Introduction
George A. Sachs, located in Farmington Hills, MI, is a distinguished inventor with an impressive portfolio of 17 patents. His pioneering work primarily focuses on innovative methods and compositions for the treatment of pancreatitis, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest patents are significant contributions to the treatment of pancreatitis. One notable patent is centered on "Methods and compositions for the treatment of acute pancreatitis in a mammal." This invention involves particular compositions that comprise a binding element, a translocation element, and a therapeutic element capable of preventing the accumulation of digestive enzymes within the pancreas. Additionally, Sachs developed "Prodrugs of proton pump inhibitors," which includes formulations that have improved aqueous solubility and bioavailability, enhancing the efficacy of treatments.
Career Highlights
Throughout his career, George A. Sachs has made substantial contributions to pharmaceutical advancements. He has worked with notable companies, including Allergan, Inc., where he further honed his expertise in developing innovative treatment solutions.
Collaborations
Sachs has collaborated with other esteemed professionals in the field, including Rango Dietrich and Michael E. Garst. These partnerships have played a crucial role in the development of his groundbreaking patents, facilitating the exchange of ideas and enhancing the quality of his research.
Conclusion
George A. Sachs stands out as a remarkable inventor whose work has the potential to significantly impact the treatment of pancreatitis and related conditions. His 17 patents reflect his dedication and ingenuity in the field of medical innovation, ensuring a lasting legacy in pharmaceutical research and development.